X

Xenon Pharmaceuticals Inc
NASDAQ:XENE

Watchlist Manager
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Watchlist
Price: 33.16 USD 8.72%
Market Cap: 2.5B USD

Intrinsic Value

The intrinsic value of one XENE stock under the Base Case scenario is 8.25 USD. Compared to the current market price of 33.16 USD, Xenon Pharmaceuticals Inc is Overvalued by 75%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

XENE Intrinsic Value
8.25 USD
Overvaluation 75%
Intrinsic Value
Price
X
Worst Case
Base Case
Best Case

Valuation History
Xenon Pharmaceuticals Inc

What is Valuation History?
Compare XENE to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about XENE?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Xenon Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Xenon Pharmaceuticals Inc

Current Assets 565.5m
Cash & Short-Term Investments 549.6m
Receivables 8.6m
Other Current Assets 7.3m
Non-Current Assets 177.7m
Long-Term Investments 141.5m
PP&E 17.3m
Other Non-Current Assets 18.9m
Efficiency

Free Cash Flow Analysis
Xenon Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Xenon Pharmaceuticals Inc

Revenue
7.5m USD
Operating Expenses
-300.5m USD
Operating Income
-293m USD
Other Expenses
41.5m USD
Net Income
-251.4m USD
Fundamental Scores

XENE Profitability Score
Profitability Due Diligence

Xenon Pharmaceuticals Inc's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

18/100
Profitability
Score

Xenon Pharmaceuticals Inc's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

XENE Solvency Score
Solvency Due Diligence

Xenon Pharmaceuticals Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Xenon Pharmaceuticals Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

XENE Price Targets Summary
Xenon Pharmaceuticals Inc

Wall Street analysts forecast XENE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XENE is 55.97 USD with a low forecast of 42.42 USD and a high forecast of 68.25 USD.

Lowest
Price Target
42.42 USD
28% Upside
Average
Price Target
55.97 USD
69% Upside
Highest
Price Target
68.25 USD
106% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Xenon Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for XENE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

XENE Insider Trading
Buy and sell transactions by insiders

XENE News

Other Videos
What is the Intrinsic Value of one XENE stock?

The intrinsic value of one XENE stock under the Base Case scenario is 8.25 USD.

Is XENE stock undervalued or overvalued?

Compared to the current market price of 33.16 USD, Xenon Pharmaceuticals Inc is Overvalued by 75%.

Back to Top